MetLife, Inc. (NYSE:MET) had its target price increased by equities researchers at Morgan Stanley from $54.00 to $55.00 in a research report issued to clients and investors on Thursday. The firm currently has an “equal weight” rating on the financial services provider’s stock. Morgan Stanley’s price target suggests a potential upside of 4.72% from the company’s previous close.

Several other research analysts also recently commented on MET. BidaskClub raised shares of MetLife from a “strong sell” rating to a “sell” rating in a research note on Saturday, June 10th. ValuEngine raised shares of MetLife from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, June 27th. Wells Fargo & Company reaffirmed a “buy” rating on shares of MetLife in a research note on Saturday, July 1st. Citigroup Inc. set a $51.00 price target on shares of MetLife and gave the stock a “sell” rating in a research note on Friday, July 7th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and issued a $62.00 price target on shares of MetLife in a research note on Wednesday, July 12th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. MetLife has an average rating of “Hold” and a consensus target price of $57.45.

Shares of MetLife (NYSE:MET) traded up 0.78% during midday trading on Thursday, hitting $52.93. 1,294,305 shares of the stock were exchanged. MetLife has a 12 month low of $40.30 and a 12 month high of $52.98. The firm has a 50 day moving average of $48.84 and a 200-day moving average of $47.58. The stock has a market cap of $56.26 billion, a P/E ratio of 622.71 and a beta of 1.47.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.28 by $0.02. The company had revenue of $17.39 billion for the quarter, compared to the consensus estimate of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The firm’s revenue was up 2.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.83 EPS. Equities research analysts anticipate that MetLife will post $4.73 EPS for the current year.

TRADEMARK VIOLATION WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international trademark and copyright law. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/05/metlife-inc-met-given-new-55-00-price-target-at-morgan-stanley.html.

Large investors have recently added to or reduced their stakes in the company. Prudential Financial Inc. boosted its holdings in shares of MetLife by 71.4% in the 2nd quarter. Prudential Financial Inc. now owns 3,672,729 shares of the financial services provider’s stock valued at $201,778,000 after buying an additional 1,529,570 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its holdings in shares of MetLife by 5.2% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,555,656 shares of the financial services provider’s stock valued at $195,348,000 after buying an additional 175,311 shares in the last quarter. Teacher Retirement System of Texas boosted its holdings in shares of MetLife by 7.2% in the 1st quarter. Teacher Retirement System of Texas now owns 822,785 shares of the financial services provider’s stock valued at $43,460,000 after buying an additional 55,508 shares in the last quarter. KBC Group NV boosted its holdings in shares of MetLife by 14.3% in the 2nd quarter. KBC Group NV now owns 1,263,802 shares of the financial services provider’s stock valued at $69,433,000 after buying an additional 157,734 shares in the last quarter. Finally, Boston Partners boosted its holdings in shares of MetLife by 0.5% in the 2nd quarter. Boston Partners now owns 2,010,623 shares of the financial services provider’s stock valued at $110,464,000 after buying an additional 9,845 shares in the last quarter. Institutional investors and hedge funds own 74.27% of the company’s stock.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.